Relafen 750, pharmacologically known as naproxen sodium , offers a unique metabolic pathway of action. From a pharmaceutical angle , it functions primarily as a non-copyrightal compound , inhibiting prostaglandin enzymes – specifically COX-1 and COX-2 – to reduce inflammation and fever . The ensuing decrease in inflammatory mediator synthesis i